| Synonyms: | |
| Status: | Phase 3 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 3KX376GY7L |
| InChI Key | WHUUTDBJXJRKMK-VKHMYHEASA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C5H9NO4 |
| Molecular Weight | 147.13 |
| AlogP | -0.74 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 4.0 |
| Polar Surface Area | 100.62 |
| Molecular species | ZWITTERION |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 10.0 |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Sleep Wake Disorders | 3 | D012893 | ClinicalTrials |
| Resources | Reference |
|---|---|
| CAS NUMBER | 56-86-0 |
| ChEBI | 16015 |
| ChEMBL | CHEMBL575060 |
| DrugBank | DB00142 |
| DrugCentral | 1310 |
| EPA CompTox | DTXSID5020659 |
| FDA SRS | 3KX376GY7L |
| Human Metabolome Database | HMDB0000148 |
| Guide to Pharmacology | 1369 |
| KEGG | C00025 |
| PDB | GGL |
| PharmGKB | PA449776 |
| PubChem | 33032 |
| SureChEMBL | SCHEMBL2202 |
| ZINC | ZINC000001482113 |